The report states that medical cannabis makes up the biggest part of the market segment, taking up most of the revenue shares based on 2019 figures at 71%. This is attributed to the increasing adoption of cannabis as a legitimate alternative to pharmaceuticals, especially for treating life-threatening conditions including cancer, Parkinson’s disease, Alzheimer’s disease, arthritis, and neurological disorders among others. There is also a rising demand for effective painkillers as well as chronic pain medications for the elderly, and this is where much product demand is expected to be seen.